Empowered Therapy By Tara Lorenz, Pllc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 722 N Main St Unit 4b, Watford City, ND 58854 Phone: 701-444-3979 Fax: 701-444-3944 |
News Archive
New research links outdoor air pollution -; even at levels deemed safe -; to an increased risk of diabetes globally, according to a study from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System.
The Institute for Quality and Efficiency in Health Care (IQWiG) has investigated the reliability of diagnosing bronchial asthma in children aged between 2 and 5 years, and the benefit that the test results can have for these patients. IQWiG published its final report in August 2009. According to the report, the available studies do not reveal any diagnostic procedure to be particularly suitable. It also remains unclear whether the treatment given based on the test results can benefit the patients.
The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule does not adequately protect the privacy of people's personal health information and hinders important health research discoveries, concludes a new report from the Institute of Medicine.
InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is EsbrietĀ®.
The Senate is battling over a proposed amendment that would allow prescription drugs to be imported from other countries where prices are lower.
› Verified 8 days ago